Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches

Bibliographic Details
Main Author:	Vinayak Singh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	tuberculosis drug discovery drug target drugs Mycobacterium tuberculosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2021.755459/full

Similar Items

Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01)

Pangenome Analysis of Mycobacterium Tuberculosis Reveals Core-Drug Targets and Screening of Promising Lead Compounds for Drug Discovery
by: Hamza Arshad Dar, et al.
Published: (2020-11-01)

Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
by: Aaron Goff, et al.
Published: (2020-07-01)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
by: Alexander D.H. Kingdon, et al.
Published: (2021-01-01)

Two Decades of TB Drug Discovery Efforts—What Have We Learned?
by: Balachandra Bandodkar, et al.
Published: (2020-08-01)

Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis
by: Sherry L. Mowbray, et al.
Published: (2014-08-01)

Editorial: New Approaches Against Drug-Resistant M. tuberculosis
by: Yossef Av-Gay, et al.
Published: (2021-04-01)

Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs
by: Jonnalagadda Padma Sridevi, et al.
Published: (2014-01-01)

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli
by: Angelo Iacobino, et al.
Published: (2017-01-01)

Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01)

Tuberculosis: Past, present and future of the treatment and drug discovery research
by: Ameya D. Bendre, et al.
Published: (2021-01-01)

Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
by: Makhoba XH, et al.
Published: (2020-08-01)

Advances in Mycobacterium siderophore-based drug discovery
by: Jun-li He, et al.
Published: (2011-06-01)

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
by: H. M. Adnan Hameed, et al.
Published: (2018-04-01)

Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery
by: Amine Namouchi, et al.
Published: (2017-07-01)

Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis
by: Divneet Kaur, et al.
Published: (2017-12-01)

Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in <i>Mycobacterium tuberculosis</i>
by: Caroline Shi-Yan Foo, et al.
Published: (2020-03-01)

Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them
by: Dimitrios Evangelopoulos, et al.
Published: (2015-03-01)

Wild-type minimal inhibitory concentration distributions of secondline drugs in mycobacterium tubercolosis complex clinical isolated in relation to recommended critical concentrations in Limpopo Province, South Africa
by: Seloma, Ngwanamohuba Mologadi
Published: (2017)

Extensively-drug resistant tuberculosis: A new strain and future challenge
by: Ratikorn Gamngoen, et al.
Published: (2015-01-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

The application of tetracycline-regulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis
by: Joanna Catherine Evans, et al.
Published: (2015-08-01)

EFFECT OF SOME MEDICINAL PLANTS ON GROWTH OF MYCOBACTERIUM TUBERCULOSIS, MULTI DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM OTHER THAN TUBERCULOSIS
by: Prashant Shukla, et al.
Published: (2013-12-01)

<i>Mycobacterium tuberculosis</i> Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
by: José E. S. Nunes, et al.
Published: (2020-03-01)

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi
by: Annie Zhang, et al.
Published: (2018-06-01)

Drug-resistant Mycobacterium tuberculosis, Taiwan
by: Ruwen Jou, et al.
Published: (2006-05-01)

Genotypic and phenotypic heterogeneity of Mycobacterium tuberculosis recovered from patients with pulmonary disease involving drug-resistant tuberculosis
by: Axcell, Amanda
Published: (2014)

Contribution to the research on drug resistant Mycobacterium tuberculosis
by: Stoffels, Karolien
Published: (2014)

Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets
by: Suhas Vasaikar, et al.
Published: (2016-11-01)

Anti tuberculosis drug resistance in west of Iran
by: Parviz Mohajeri, et al.
Published: (2014-01-01)

Development of Delpazolid for the Treatment of Tuberculosis
by: Young Lag Cho, et al.
Published: (2020-03-01)

Current perspectives in drug discovery against tuberculosis from natural products
by: Joseph Mwanzia Nguta, et al.
Published: (2015-01-01)

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds
by: Guilherme Felipe dos Santos Fernandes, et al.
Published: (2017-06-01)

Nature of resistance Mycobacterium tuberculosis to antymycobacterial drugs in patients with pulmonary tuberculosis with bacterioexcretion
by: O. Z. Zarichna, et al.
Published: (2011-12-01)

Tuberculosis drug resistance isolates from pulmonary tuberculosis patients, Kassala State, Sudan
by: Fatima A Khalid, et al.
Published: (2015-01-01)

Identification of Mycobacterium tuberculosis BioA inhibitors by using structure-based virtual screening
by: Singh S, et al.
Published: (2018-05-01)

Viability of causative pathogen in patients with drug-sensitive and drug-resistant forms of respiratory tuberculosis
by: E. Yu. Zorkaltseva, et al.
Published: (2017-09-01)

Anti-tuberculosis therapy: Urgency for new drugs and integrative approach
by: Lingaraja Jena, et al.
Published: (2018-01-01)

Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
by: Catherine Vilchèze
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_isettv20lc5gd00404dg88879c